XML 65 R50.htm IDEA: XBRL DOCUMENT v3.21.1
SHARE-BASED PAYMENTS - Narrative (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share) $ 3.93   $ 1.77  
Number of options (in shares) 1,471,060   1,609,087 1,487,433
Outstanding options, weighted average exercise price (in dollars per share) $ 3.02   $ 2.91 $ 3.43
Stock Incentive Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Common stock, shares authorized (in shares) 14,081,650      
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 2 years      
Award exercise period 5 years      
Exercisable options, weighted average remaining contractual term 2 years 8 months 15 days      
Number of grants in period (in shares) 160,000 570,000    
Number of options (in shares) 1,470,000      
Number of exercisable options (in shares) 1,180,000      
Outstanding options, weighted average exercise price (in dollars per share) $ 3.02      
Exercisable options, weighted average exercise price (in dollars per share) $ 3.17      
Options, vested and expected to Vest, aggregate intrinsic value $ 3,170,000      
Share-based compensation 200,000 $ 260,000    
Unrecognized compensation costs related to unvested stock options $ 180,000      
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition 1 year 7 months 24 days      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 2 years 11 months 1 day      
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 3 years      
Granted, nonvested, number of shares (in shares) 440,000 740,000    
Grants in period, grant date intrinsic value (in dollars per share) $ 2,670,000 $ 1,210,000    
Share-based compensation $ 360,000 $ 410,000    
Unrecognized compensation costs related to RSU awards $ 1,880,000      
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition 2 years 6 months 25 days      
Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period       5 years
Number of grants in period (in shares)       2,200,000
Grants in period, weighted average exercise price (in dollars per share)       $ 1.25
Granted, nonvested, number of shares (in shares) 0   0  
Share-based compensation $ 140,000 $ 330,000    
Unrecognized compensation costs related to RSU awards $ 140,000      
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition 6 months 21 days      
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share) $ 7.14   $ 3.06  
Outstanding options, weighted average exercise price (in dollars per share) $ 12.59   $ 15.61 15.61
Maximum | Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Exercisable options, weighted average remaining contractual term 10 years      
Share-based Compensation Award, Tranche One | Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share)       $ 5.00
Period of exercise price       90 days
Share-based Compensation Award, Tranche Two | Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share)       $ 7.00
Period of exercise price       90 days
Share-based Compensation Award, Tranche Three | Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share)       $ 10.00
Period of exercise price       90 days
Common Stock | Stock Appreciation Rights (SARs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants in period, weighted average exercise price (in dollars per share)       $ 2.92